PortfoliosLab logoPortfoliosLab logo
MRK vs. SAABY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MRK vs. SAABY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Saab AB (publ) (SAABY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MRK achieves a 14.39% return, which is significantly higher than SAABY's -3.10% return.


MRK

1D
-1.05%
1M
7.31%
YTD
14.39%
6M
22.75%
1Y
56.85%
3Y*
5.78%
5Y*
13.57%
10Y*
11.61%

SAABY

1D
1.56%
1M
-4.17%
YTD
-3.10%
6M
4.44%
1Y
6.53%
3Y*
60.83%
5Y*
51.19%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRK vs. SAABY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
MRK
Merck & Co., Inc.
14.39%9.79%-6.26%1.01%49.42%1.75%1.05%
SAABY
Saab AB (publ)
-3.10%177.56%39.85%47.07%67.28%-48.79%82.51%

Correlation

The correlation between MRK and SAABY is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.00

Correlation (All Time)
Calculated using the full available price history since Apr 15, 2020

-0.00

Fundamentals

Market Cap

MRK:

$295.45B

SAABY:

$30.33B

EPS

MRK:

$3.58

SAABY:

$5.98

PE Ratio

MRK:

33.34

SAABY:

4.69

PEG Ratio

MRK:

0.03

SAABY:

0.14

PS Ratio

MRK:

4.54

SAABY:

0.37

PB Ratio

MRK:

6.44

SAABY:

0.68

Total Revenue (TTM)

MRK:

$65.59B

SAABY:

$82.29B

Gross Profit (TTM)

MRK:

$49.79B

SAABY:

$17.87B

EBITDA (TTM)

MRK:

$22.69B

SAABY:

$9.44B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MRK vs. SAABY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRK
MRK Risk / Return Rank: 9090
Overall Rank
MRK Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 9090
Sortino Ratio Rank
MRK Omega Ratio Rank: 8686
Omega Ratio Rank
MRK Calmar Ratio Rank: 9292
Calmar Ratio Rank
MRK Martin Ratio Rank: 9191
Martin Ratio Rank

SAABY
SAABY Risk / Return Rank: 4646
Overall Rank
SAABY Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
SAABY Sortino Ratio Rank: 4545
Sortino Ratio Rank
SAABY Omega Ratio Rank: 4343
Omega Ratio Rank
SAABY Calmar Ratio Rank: 4747
Calmar Ratio Rank
SAABY Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRK vs. SAABY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Saab AB (publ) (SAABY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MRKSAABYDifference
Sharpe ratioReturn per unit of total volatility

+1.96

Sortino ratioReturn per unit of downside risk

+2.50

Omega ratioGain probability vs. loss probability

1.36

1.06

+0.30

Calmar ratioReturn relative to maximum drawdown

5.03

0.18

+4.85

Martin ratioReturn relative to average drawdown

12.59

0.45

+12.14

MRK vs. SAABY - Sharpe Ratio Comparison

The current MRK Sharpe Ratio is 2.10, which is higher than the SAABY Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of MRK and SAABY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MRKSAABYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.10

0.13

+1.96

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.58

1.10

-0.52

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.48

0.77

-0.29

Drawdowns

MRK vs. SAABY - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.61%, which is greater than SAABY's maximum drawdown of -52.75%. Use the drawdown chart below to compare losses from any high point for MRK and SAABY.


Loading charts...

Drawdown Indicators


MRKSAABYDifference

Max Drawdown

Largest peak-to-trough decline

-68.61%

-52.75%

-15.86%

Max Drawdown (1Y)

Largest decline over 1 year

-11.37%

-37.04%

+25.67%

Max Drawdown (3Y)

Largest decline over 3 years

-43.44%

-37.04%

-6.40%

Max Drawdown (5Y)

Largest decline over 5 years

-43.44%

-37.04%

-6.40%

Max Drawdown (10Y)

Largest decline over 10 years

-43.44%

Current Drawdown

Current decline from peak

-4.65%

-30.86%

+26.21%

Average Drawdown

Average peak-to-trough decline

-18.84%

-16.93%

-1.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

14.58%

-10.05%

Volatility

MRK vs. SAABY - Volatility Comparison

The current volatility for Merck & Co., Inc. (MRK) is 9.44%, while Saab AB (publ) (SAABY) has a volatility of 15.81%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than SAABY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MRKSAABYDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.44%

15.81%

-6.37%

Volatility (6M)

Calculated over the trailing 6-month period

18.14%

32.83%

-14.69%

Volatility (1Y)

Calculated over the trailing 1-year period

27.30%

49.42%

-22.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.71%

46.99%

-23.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.96%

57.54%

-34.58%

Dividends

MRK vs. SAABY - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 2.78%, more than SAABY's 0.42% yield.


PositionTTM20252024202320222021202020192018201720162015
MRK
Merck & Co., Inc.
2.78%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%
SAABY
Saab AB (publ)
0.42%0.36%0.73%0.84%1.24%2.19%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MRK vs. SAABY - Financials Comparison

This section allows you to compare key financial metrics between Merck & Co., Inc. and Saab AB (publ). You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B20222023202420252026
16.29B
19.16B
(MRK) Total Revenue
(SAABY) Total Revenue
Values in USD except per share items

MRK vs. SAABY - Profitability Comparison

The chart below illustrates the profitability comparison between Merck & Co., Inc. and Saab AB (publ) over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
81.9%
23.4%
Portfolio components
MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

SAABY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Saab AB (publ) reported a gross profit of 4.48B and revenue of 19.16B. Therefore, the gross margin over that period was 23.4%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

SAABY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Saab AB (publ) reported an operating income of 1.91B and revenue of 19.16B, resulting in an operating margin of 10.0%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.

SAABY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Saab AB (publ) reported a net income of 1.44B and revenue of 19.16B, resulting in a net margin of 7.5%.


Frequently Asked Questions


MRK and SAABY have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SAABY has higher volatility (15.81%) compared to MRK (9.44%). In terms of maximum drawdown, MRK dropped -68.61% vs SAABY's -52.75%.

MRK currently has the higher Sharpe Ratio (2.10 vs 0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MRK and SAABY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer